Gianna Melillo

Deepak L. Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital Heart & Vascular Center and professor of medicine at Harvard Medical School, discusses whether sodium glucose co-transporter 1 (SGLT1) inhibitors can yield stroke benefits in patients with type 2 diabetes.

Investigators explored the associations between body weight and pediatric-onset multiple sclerosis.

Results of a UK Biobank study outline the association between migraine and several gastrointestinal disorders.

Here are some of the latest developments in multiple sclerosis (MS) from our sister publication, NeurologyLive®.

Results of a survey study underscore the variables considered most and least important to patients and general practitioners when it comes to migraine treatments.

New research shows that independent of other forms of physical activity, biking is associated with reduced mortality rates among adults with diabetes.

In a new review, researchers assessed the negative impacts of glycemic variability on cognitive function and brain structure among youth with type 1 diabetes.

Catlin Dennis, MPH, describes the challenges socially and medically vulnerable youth with diabetes and their families faced during the COVID-19 pandemic.

Ezio Bonifacio, PhD, explains factors associated with childhood type 1 diabetes incidence and why more research is needed among minority populations.

Bobeck Modjtahedi, MD, highlights some of the challenges of using telehealth to treat individuals with diabetic retinopathy.

New research underscores the strong association seen between migraine, hearing loss, and tinnitus among US adults.

Research indicates those with pediatric-onset multiple sclerosis (POMS) may have reduced memory performance compared with healthy controls.

Researchers assess mortality rates among those with just asthma, just atopic dermatitis, and individuals with both conditions in Denmark.

Researchers investigated whether responses to questionnaires on psoriasis and atopic dermatitis prevalence remained consistent over time.

In Germany, rates of diabetic ketoacidosis (DKA) seen at time of type 1 diabetes (T1D) diagnosis were stable throughout the past 2 decades.

New data from the REACH3 trial show ruxolitinib resulted in positive outcomes among those with chronic graft-vs-host disease (GVHD).

Here are some of the latest developments in multiple sclerosis (MS) from our sister publication, NeurologyLive®.

Highlighting the latest migraine-related news reported across MJH Life Sciences™.

Ann Goebel-Fabbri, PhD, a clinical psychologist in Boston, Massachusettes, discusses how limited research on patients with type 1 diabetes (T1D) and eating disorders hinders progress on developing effective interventions.

Results of a retrospective observational study indicate good adherence to disease-modifying therapies (DMTs) for multiple sclerosis (MS) is associated with better outcomes among veterans with the disease.

A string of controversies surrounding the approval of Biogen's Alzheimer disease drug aducanumab (Aduhelm) has not only called into question the independent nature of the FDA, but puts both providers and patients in a challenging position when it comes to deciding whether or not to prescribe or take the treatment.

Michelle Litchman, PHD, FNP-BC, FAANP, FADCES, an assistant professor at the College of Nursing at the University of Utah, describes the results of a study that looked at diabetes technology use and online peer support systems among Spanish-speaking patients. Findings showed that when these 2 interventions are used in conjunction, a positive feedback loop forms.

David McIntyre, MD, FRACP, describes different methods of diagnosing gestational diabetes around the world.

New data underscore how obesity, racial disparities and recent treatment advancements have impacted cancer mortality and incidence rates.

Mary Pat Gallagher, MD, of NYU Langone Health, discusses research needed to better understand how COVID-19 impacts individuals with diabetes.

Results of an online survey indicated that remote electrical neuromodulation (REN) may serve as a nonpharmocological treatment option for patients with menstrual migraine.

The FDA issued a Complete Response Letter, halting Provention Bio's type 1 diabetes prevention drug.

ZUMA-7 results indicate axicabtagene ciloleucel (Yescarta) improves event-free survival among adult patients with second-line relapsed or refractory large B-cell lymphoma (LBCL).

To mark National Gun Violence Awareness Month, The American Journal of Managed Care® assessed how events in 2020 shaped the United States' gun violence epidemic.

New research illustrates the potential benefits of erenumab among migraineurs in the United States.